Evidence map›Paper›PMID 42626316›Full record

ArticleBioinorganic chemistry and applications2026

All Platinum(II) Ions Are Equal, but Some React Differently: Insights Into the Biomolecular Reactivity of Platinum(II)-Based Anticancer Agents.

Andrea Cucchiaro, Monika Cziferszky

Abstract read
In one paragraph

Article in Bioinorganic chemistry and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrea CucchiaroInstitute of Pharmacy, Pharmaceutical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria, uibk.ac.at.ORCID https://orcid.org/0000-0002-3324-7005
Monika CziferszkyInstitute of Pharmacy, Pharmaceutical Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80/82, Innsbruck A-6020, Austria, uibk.ac.at.ORCID https://orcid.org/0000-0002-3654-7812

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platinum-based anticancer agents are widely used in cancer therapy due to their efficacy in killing cancer cells through interactions with the DNA. However, their clinical application is limited by severe side effects and the development of drug resistance, which have been related to their lack of specificity and mechanism of action. To overcome these challenges, novel platinum(II) complexes, K[Pt(Butene-ASA)Cl

Identifiers

PMID42626316
PMCPMC13491152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.